Promethos Capital, LLC Collegium Pharmaceutical, Inc Transaction History
Promethos Capital, LLC
- $264 Billion
- Q2 2024
A detailed history of Promethos Capital, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Promethos Capital, LLC holds 150 shares of COLL stock, worth $5,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$5,175
Previous $5.82 Million
17.05%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding COLL
# of Institutions
247Shares Held
40.3MCall Options Held
84.2KPut Options Held
19.6K-
Black Rock Inc. New York, NY5.79MShares$200 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.41MShares$118 Million0.28% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$90.9 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.37MShares$81.8 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.33MShares$80.5 Million2.23% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.18B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...